Why MIS-C cases are dropping dramatically across the US: Experts
A combination of immunity from COVID-19 infection and vaccination, as well as less severe variants, may have led to a drop in diagnoses of MIS-C.
Related Articles
Why does TB have such a hold on the Inuit communities of the Canadian Arctic?
Canada has one of the world’s lowest rates of tuberuclosis. Yet this deadly disease is surging among Indigenous people in this icy, remote part of…
US funders to tighten oversight of controversial ‘gain-of-function’ research
Nature – New policy on high-risk biology studies aims to address criticism that previous rules were too vague.
Whooping cough epidemic sweeps Europe, health agency says
European countries have reported a surge in whooping cough cases in 2023 and the first quarter of 2024, with 10 times as many identified as…
‘Unqualified failure’ in polio vaccine policy left thousands of kids paralyzed
Well-intentioned decision to switch oral polio vaccines in 2016 backfired, new draft report says
Pediatric COVID-19 Not Linked to New Asthma Diagnosis
Researchers assessed whether SARS-CoV-2 infection in children modified their risk for incident asthma within 18 months post infection.
Poor RSV Outcomes Linked With Higher Levels of Social Vulnerability
Researchers evaluated the relationship between social vulnerability and the risk for hospitalization among patients with respiratory syncytial virus.
Bird Flu: 100 Million Doses of Vaccine Could Be Shipped Within Months
There is no sign that the H5N1 bird flu circulating in dairy cow herds is developing the ability to spread easily to people. But federal…
Doctors Warn About 2 New COVID Variants—What to Know About ‘FLiRT’ Strains
Experts warn these strains may lead to a summer surge—here’s how to stay safe.
BARDA announces first next-generation countermeasure accelerator hubs
One hub focuses on diagnostics and medical devices, and the other targets therapeutics and vaccines.
Funders join forces to address antimicrobial resistance, other global health challenges
Wellcome, the Novo Nordisk Foundation, and the Bill & Melinda Gates Foundation will each donate $100 million to the joint initiative.